Clinical Trials Directory

Trials / Completed

CompletedNCT00707044

Short-Stay Intensive Care for Coronary Artery Bypass Patients

Short-Stay Intensive Care for Coronary Artery Bypass Patients,Development of a Guideline for Giving Adequate Care on the Cardiosurgical Intensive Care

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
597 (actual)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
18 Years – 78 Years
Healthy volunteers
Not accepted

Summary

Objective: To evaluate the safety and cost-effectiveness of Short Stay Intensive Care (SSIC) treatment for low-risk coronary artery bypass patients Design: Randomized clinical equivalence trial Setting: University Hospital Maastricht, the Netherlands Patients: low-risk coronary artery bypass patients Interventions: 600 patients were randomly assigned to undergo either SSIC treatment (8 hours Intensive Care) or control treatment (care as usual, overnight Intensive Care). Measurements: The primary outcome measures were Intensive Care (IC) readmissions and total hospital stay. The secondary outcome measures were total hospital costs, Quality of Life (QoL), postoperative morbidity and mortality. Hospital costs consisted of the cost of hospital admission(s) and outpatient costs.

Conditions

Interventions

TypeNameDescription
PROCEDUREControl group (usual care)control group, care as usual, 24 hours intensive care stay
PROCEDUREShort-Stay Intensive Care treatment (SSIC)Short-Stay Intensive Care treatment (SSIC), 8 hours of Intensive care treatment

Timeline

Start date
2001-01-01
Primary completion
2003-10-01
Completion
2004-05-01
First posted
2008-06-30
Last updated
2017-02-24

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT00707044. Inclusion in this directory is not an endorsement.